28. Ghika J, Tennis M, Hoffman E, et al: Idazoxan treatment in
     progressive supranuclear palsy. Neurology 41:986, 1991
 29. Gibb WRG, Lees AJ: Anatomy, pigmentation, ventral and dorsal
     subpopulations of the substantia nigra, and differential cell death
     in Parkinson's disease. j Neurol Neurosurg Psych 54:388, 1991
 30. Gibb WRG, Luthert PJ, Janota I. Lantos PL: Cortical Lewy body
     dementia: Clinical features and classification. J Neurol Neurosurg
     Psych 52:185, 1989
 31. Gibb WRG, Luthert PJ, Marsden CD: Clinical and pathological features
     of corticobasal degeneration. Adv Neurol 53:51, 1990
 32. Gibb WRG, Mountjoy CQ, Mann DMA. Lees AJ: The substantia nigra and
     ventral tegmental area in Alzheimer's disease and Down's syndrome
     J Neurol Neumsurg Psych 52:193, 1989
 33. Gibb WRG, Scott T, Lees AJ: Neuronal inclusions of Parkinson's
     disease. Mov Disorders 6:2, 1991
 34. Gilaldi N, Burke RE, Kostic V, et al: Hemiparkinsonism-hemiatrophy
     syndrome. Neurology 40:1731, 1990
 35. Gilbert JJ, Kish SJ, Chang L-J, et al: Dementia, parkinsonism and
     motor neuron disease: Neurochemical and neuropathological correlates.
     Ann Neurol 24:688, 1988
 36. Gilman S, Markel DS, Koeppe RA, et al: Cerebellar and brainstem
     hypometabolism in olivupontocerebellar atrophy with positron emission
     tomography. Ann Neurol 23:223, 1988
 37. Goffinet AM, De VoIder AG, Gillian C, et al: Positron tomography
     demonstrates frontal lobe hypometabolism in progressive supranuclear
     palsy. Ann Neurol 25:131, 1989
 38. Goldstein DS. Polinsky RJ, Garty M, et al: Patterns of plasma levels
     of catechols in neurogenic orthostatic hypotension. Ann Neurol
     26:558, 1989
 39. Goto S, Hirano A. Matsumoto S: Immunohistochemical study of the
     striatal efferents and nigral dopaminergic neurons in parkinsonism-
     dementia complex on Guam in comparison with those in Parkinson's
     and Alzheimer's disease. Ann Neurol 27:520, 1990
 40. Goto S, Hirano A, Matsumoto S: Met-enkephalin immunoreactivity in the
     basal ganglia in Parkinson's disease and striatonigraI degeneration.
     Neurology 40:1051, 1990
 41. Grafman J, Litvan I, Gomez C, Chase T: Frontal lobe function in
     progressive supranuclear palsy. Arch Neurol 47:553, 1990
 42. Graham JG, Oppenheimer DR: Orthostatic hypotension and nicotinic
     sensitivity in a case of multiple system atmphy. I Neurol Neurosurg
     Psych 32:28, 1969
 43. Gray F, Vincent D, Hauw JJ: Quantitative study of lateral horn cells
     in 15 cases of multiple system atrophy. Acta Neuropath 75:513, 1988
 44. Hirano A, Kurland LT, Krooth RS, Lessell LS: Parkinsonism-dementia
     complex, and endemic disease on the island of Guam. Clinical features.
     11. Pathologic features. Brain 84:642, 1961
 45. Ishino H, Higashi H, Kuroda S, et al: Motor nuclear involvement in
     progressive supranuclear palsy. J Neurol Sci 22:235, 1973
 46. Jankovic J: Controlled trial of pergolide mesylate in Parkinson's
     disease and progressive supranuclear palsy. Neurology 33:505, 1983
 47. Jankovic J: Apraxia of eyelid opening in progressive supranuclear
     palsy. Ann Neurol 15:115, 1984
 48. Jankovic J: Progressive supranuclear palsy: Clinical and
     pharmacologic update. Neurol Clin 2:473, 1984
 49. Jankovic J: Parkinson's plus syndromes. Mov Disorders 4:595, 1989
 50. Jankovic J: The relationship between Parkinson's disease and other
     movement disorders. In CaIne DB (ed): Handbook of Experimental
     Pharmacology, Vol 88. Berlin, Springer-Verlag, 1989, p 227
 51. Jankovic J, Brin MF: Therapeutic uses of botulinum toxin. N EngI
     J Med 324:1186, 1991
 52. Jankovic J, Friedman DI, Pirozzolo FJ, McCrary JA: Progressive
     supranuclear palsy: Motor, neurobehavioral, and neuro-ophthalmic
     findings. Adv Neurol 53:293, 1990
 53. Jankovic J,Bilden JL, Hiner BC, et al: Neurogenic orthostatic
     hypotension: A doubleblind placebo-controlled study with midodrine.
     Neurology 41(suppl 1):284, 1991
 
 54. Jankovic J, McDermott M, Carter J, et al: Variable expression of
     Parkinson's disease: A baseline analysis of the DATATOP' cohort.
     Neurology 40:1529. 1990
 55. Joachim CL, Morris JII, Kosik KS, Seldoe DJ: Tau antisera recognize
     neurofibrillary tangles in a range of neurodegenerative disorders.
     Ann Neurol 18:523, 1985
 56. Jume A, Takashi A. Hashizume Y, Asai J: A histometrical and
     comparative study on Purkinje cell loss and olivary nucleus cell loss
     in multiple system atrophy. J Neurol Neurosci 101:178, 1991
 57. Juncos JL, Hirsch EC. Malessa S, et al: Mesencephalic cholinergic
     nuclei in progressive supranuclear palsy. Neurology 41:25, 1990
 58. Kato S, Nakamura H: Cytoplasmic argyophilic inclusions in neurons of
     pontine nuclei in patients  with olivopontocerebellar atrophy:
     Immunohistochemical and ultrastructural studies. Acta Neuropath
     (Berlin) 79:584, 1990
 59. Kaye JA, May C, Daly E, et al: Cerebrospinal fluid monoamine markers
     are decreased in dementia of the Alzheimer type with extrapyramidal
     features. Ann Neurol 38:554. 1988
 60. Kertzman C, Robinson DL, Litvan I: Effects of physostigmine on spatial
     attention in patients with progressive supranuclear palsy. Arch
     Neuml 47:1346, 1990
 61. Kish SJ, Du F, Parks DA, et al: Quinolinic acid catabolism is
     increased in cerebellum of patients with dominantly inherited
     olivopontocerebellar atrophy. Ann Neurol 29:100, 1991
 62. Koeppen AH, Mitzen EJ, Hans MC, Barron KD: Olivopontocerebellar
     atrophy; immunocytochemical and Golgi observations. Neumlogy
     36:1478, 1986
 63. Kosaka K, Matsushita R. Oyanagi S, et al: Pallido-nigral-luysial
     atrophy with massive appearence of corpora amylacea in the CNS.
     Acta Neuropath (Berlin) 53:169, 1981
 64. Kosic KS: Alzheimer's plaques and tangles: Advances on both fronts.
     Trends Neurosci 14:218, 1991
 65. Kostic VS, Mojsilvoc LJ, Stojanovic M: Degenerative neurological
     disorders associated with a deficiency of glutamate dehydrogenase.
     J Neurol 236:111. 1989
 66. Lepore FE. Duvoisin RC: "Apraxia" of eyelid opening: An involuntary
     levator inhibition. Neurology 35:423, 1985
 67. Lepore FE, Steele JC, Cox TA, et al: Supwnuclear disturbances of
     ocular motility in Lytico-Bodig. Neurology 38:1849, 1988
 68. Lewis AJ, Gawel MJ: Diffuse Lewy body disease with dementia and
     oculomotor dysfunction. Mov Disorders 5:143-147. 1991
 69. Lippa CF, Smith TW, Fontneau N: Corticonigral degeneration with
     neuronal achromasia. J Neurol Sci 98:301, 1990
 70. Litvan I, Grafman J, Gomez C, Chase T: Memory impairment in patients
     with progressive supranuclear palsy. Arch Neurol 46:765, 1989
 71. Lou JS, Jankovic J: Essential tremor: Clinical correlates in 350
     patients. Neurology 41:234, 1991
 72. Maher ER, Lees AJ: The clinical features and natural history of Steel-
     Richardson-Olszewski (progressive supranuclear palsy). Neurology
     36:1005, 1986
 73. Makoweic RL, Albin RL, Cha JJ, et al: Two types of quisqualate
     receptors are decreased in human olivopontocerebellar atrophy
     cerebellar cortex. Brain Res 523:309, 1990
 74. Malessa S, Hirsch EC, Cervera P, et al: Catecholamingeric systems in
     the medulla oblongata in parkinsonian syndromes. Neurology 40:1739,
     1990
 75. Matsumoto S, Hirano A, Goto S: Spinal cord neurofibrillary tangle of
     Guamanian amyotrophic lateral sclerosis and parkinsonism-dementia
     complex. Neurology 40:975, 1990
 76. Matsuo H, Takashima H. Kishikawa M, et al: Pure akinesia: An atypical
     manifestation of progressive supranuclear palsy. J Neurol
     Neurosurg Psych 54:397, 1991
 77. Mayeux R, Stern Y. Spanton S: Heterogeneity in dementia of the
     Alzheimer's type: Evidence of subgroups. Neurology 35:453, 1985
 78. McLeod JO, Tuck RIt: Disorders of the autonomk nervous system: Part 1.
Path',
     physiology and dinical features. Ann Neurol 21:419, 1987
 79. McLeod JG, Tuck RR: Disorders of the autonomic nervous system:
     Part 2. Investigation and treatment. Ann Neurol 21:519. 1987
 80. de la Monte SM. Wells SE, Hedley-Whyte ET, Growdon JH:
     Neuropathological
 
     distinction between Parkinson's dementia and parkinson's plus
     Alzheimer's disease. Ann Neurol 26:309. 1989
 81. Munschauer FE. Loh L. Bannister R, Newsom-Davis J: Abnormal
     respiration and sudden death during sleep in multiple system atrophy
     with autonomic failure. Neurology 40:677. 1990
 82. Nakazato Y, Yamazaki HY, Hirato J, et al: Oligodendroglial
     microtubular tangles in olivopontocerebellar atrophy. J Neuropath
     Exp Neurol 49:521, 1990
 83. Newman GC: Treatment of progressive supranuclear palsy with tricyclic
     antidepressants. Neurology 35:1189, 1985
 84. Nygaard TG. Duvoisin RC. Manocha M. Chokroverty S: Seizures in
     progressive supranuclear palsy. Neurology 39:138. 1989
 85. O'Brien C, Sung JH, McGeachie RE, Lee MC: 5triatonigral degeneration:
     Clinical, MRI, and pathologic correlation. Neurology 40:710, 1990
 86. Pakkenberg B, Moller A, Gundersen HJG. et al: The absolute number of
     nerve cells in substantia nigra in normal subjects and in patients
     with Parkinson's disease estimated with an unbiased stereological
     method. J Neurol Neurosurg Psych 54:30. 1991
 87. Papp M. Kahn JE. Lantos PL: Glial cytoplasmic inclusions in the CNS
     of patients with multiple atrophy (striatonigral degeneration,
     olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol
     Sci 94:79. 1989
 88. Pastakia B. Polinsky R, Di Chiro G, et al: Multiple system atrophy
     (Shy-Drager syndrome): MR imaging. Radiology 159:499, 1986
 89. Perry TL, Hansen S, Jones K: Brain amino adds and glutathione in
     progressive supranuclear palsy. Neurology 38:943, 1988
 90. Pierot L, Desnos L. Blin J, et al: Dl and D2-type dopamine receptors
     in patients with Parkinson's disease and progressive supranuclear
     palsy. J Neurol Sci 86:291. 1988
 91. Pillon B, Dubois B, Ploska A. Agid Y: Severity and specificity of
     cognitive impairment Alzheimer's, Huntington's, and Parkinson's
     diseases and progressive supranuclear palsy. Neurology 41:634, 1991
 92. Polinsky RJ: Shy Drager Syndrome. In Jankovic J, Tolosa E, (eds):
     Parkinson's Disease and Other Movement Disorders. Baltimore, Urban
     & Schwarzenberg, 1988, p 121
 93. Polinsky RJ. Holmes KV. Brown RT. Weise V: CSF acetylcholinesterase
     levels are reduced in multiple system atrophy with autonomic failure.
     Neurology 39:40, 1989
 94. Quinn N: Multiple system atrophy. In Marsden CD, Fahn S (eds):
     Movement Disorders 3. Butterworths, London, in press. 1992
 95. Rafal RD, Posner MI. Friedman D. et al: Orienting of visual attention
     in progressive supranuclear palsy. Brain 111:267, 1988
 96. Rebeiz JJ. Kolodny EH, Richardson EP: Corticodentatonigral
     degeneration with neuronal achromasia. Arch Neurol 18:20, 1968
 97. Riley DE. Lang AE, Lewis A, et at: Cortical-basal ganglionic
     degeneration. Neurology 40:1203. 1990
 98. Rivest J. Quinn N. Marsden CD: Dystonia in Parkinson's disease,
     multiple system atrophy. and progressive supranuclear palsy.
     Neurology 40:1571. 1990
 99. Saper CB. Sorrentino DM, German DC, de Lacalle S: Medullary
     catecholaminergic neurons in the normal human brain and in
     Parkinson's disease. Ann Neurol 29:577, 1991
100. Sawle GV. Brooks DJ. Marsden CD. Frackowiak SJ: Corticobasal
     degeneration. Brain 114:541, 1991
101. Shankar SK. Yanagihara R, Garruto RM. et al: Immunocytochemical
     characterization of neurofibrillary tangles in amyotrophic lateral
     sclerosis and parkinsonism-dementia complex of Guam. Ann Neurol
     25:146, 1989
102. Shimizu N, Takiyama Y, Mizuno Y, et al: Characteristics of
     oculomotility disorders of a family with Joseph's disease.
     J Neurol 237:393, 1990
103. Shy GM. Drager GA: A neurological syndrome associated with
     orthostatic hypotension: A clinical-pathological study. Arch
     Neurol 2:511, 1960
104. Sinatra MG. Baldini SM. Baiocco F. Carenini L: Auditory brainstem
     response patterns in familial and sporadic otivopontocerebellar
     atrophy. Eur Neurol 28:288. 1988
 
105. Snow BJ, Peppard RF, Guttman M, et al: Positron emission tomographic
     scanning demonstrates a presynaptic dopaminergic lesion in Lytico-
     Bodig. Arch Neurol 47:870. 1990
106. Spencer PS, Nunn PB, Hugon JS, et al; Guam amyotrophic lateral
     sclerosis-parkinsonism and dementia linked to a plant excitant
     neurotoxin. Science 237:517, 1987
107. Steele JC: Progressive supranuclear palsy. Brain 95:693, 1972
108. Steele JC, Richardson JC, Olszewski J: Progressive supranuclear palsy;
     A heterogeneous degeneration involving the brainstem, basal ganglia
     and cerebellum with vertical gaze and pseudobulbar palsy. nuchal
     dystonia and dementia. Arch Neurol 2:473, 1964
109. Stern MB, Braffman BH, Skolnick BE, et al: Magnetic resonance imaging
     in Parkinson's disease and parkinsonian syndromes. Neurology
     39:1524, 1989
110. Tabaton M, Perry G, Autilio-Gambetti L, et al: Influence of neuronal
     location on antigenic properties of neurofibrillary tangles. Ann
     Neurol 23:604. 1988
111. Tomokane NT. Kitamoto T. Tateishi J, Sato Y: Immunohistochemical
     quantification of substance P in spinal dorsal horns of patients
     with multiple system atrophy. J Neurol Neurosurg Psych 54:535, 1991
112. Truong DD, Harding AE, Scaravilli F, et a!: Movement disorders in
     mitochondrial myopathies. Mov Disorders 5:109, 1990
113. Tyrell PJ, Sawle GV, Ibanez V, et al: Clinical and positron emission
     tomographic studies in the 'extrapyramidal syndrome' of dementia of
     the Alzheimer type. Arch Neurol 47:1318, 1990
114. Young A: Progressive supranuclear palsy: Postmortem chemical analysis.
     Ann Neurol 18:521, 1985
115. Zhang Z, Anderson DW, Lavine L, Mantel N: Patterns of acquiring
     parkinsonism-dementia complex of Guam. Arch Neurol 47:1019, 1990
116. Zweig RM, Whitehouse PJ, Casanova MF, et al: loss of pedunculopontine
     neurons in progressIve supranuclear palsy. Ann Neurol 22:18, 1985
 
Address reprint requests to
Joseph jankovic, MD
Department of Neurology
Baylor College of Medicine
6550 Fannin, 1801 Smith Tower
Houston, TX 77054
 
John Cottingham                     [log in to unmask]